Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Agios Pharmaceuticals Inc (AGIO)  
$34.58 0.92 (2.73%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 69,110,000
Market Cap: 2.39(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $19.97 - $34.81
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Agios Pharmaceuticals is a biopharmaceutical company focused on improving patients' lives in the field of cellular metabolism and adjacent areas of biology, with the goal of creating molecule medicines for genetically defined diseases (GDD). The lead product in its GDD, portfolio, PYRUKYND® (mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the potential treatment of hemolytic anemias. Co. is evaluating PYRUKYND® for the treatment of a- and B-thalassemia and sickle cell disease (SCD). Co. is also developing AG-946, a PK activator, for the potential treatment of hemolytic anemias and other indications, including SCD.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 166,465 218,053 292,572 410,176
Total Sell Value $5,544,468 $6,694,407 $8,693,794 $11,787,151
Total People Sold 8 9 9 9
Total Sell Transactions 17 28 39 48
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 822
  Page 2 of 33  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Burns James William Chief Legal Officer   •       –      –    2024-02-14 4 AS $25.14 $13,701 D/D (545) 31,666 22%     
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-02-12 4 OE $0.00 $0 D/D 2,162 34,073     -
   Washburn Theodore James Jr. Principal Accounting Officer   •       –      –    2024-02-12 4 OE $0.00 $0 D/D 777 3,518     -
   Burns James William Chief Legal Officer   •       –      –    2024-02-12 4 OE $0.00 $0 D/D 1,833 32,211     -
   Jones Cecilia Chief Financial Officer   •       –      –    2024-01-24 4 AS $21.64 $40,813 D/D (1,886) 13,069 46%     
   Burns James William Chief Legal Officer   •       –      –    2024-01-24 4 AS $21.64 $36,961 D/D (1,708) 30,378 46%     
   Goff Brian Chief Executive Officer   •       •      –    2024-01-24 4 AS $21.64 $165,221 D/D (7,635) 49,436 46%     
   Milanova Tsveta Chief Commercial Officer   •       –      –    2024-01-24 4 AS $21.64 $35,014 D/D (1,618) 13,234 46%     
   Fouse Jacqualyn A Director   –       •      –    2024-01-24 4 AS $21.64 $232,024 D/D (10,722) 129,253 46%     
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-01-24 4 AS $21.64 $36,961 D/D (1,708) 31,911 46%     
   Jones Cecilia Chief Financial Officer   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 5,380 14,955     -
   Burns James William Chief Legal Officer   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 5,750 32,086     -
   Goff Brian Chief Executive Officer   •       •      –    2024-01-20 4 OE $0.00 $0 D/D 17,018 57,071     -
   Milanova Tsveta Chief Commercial Officer   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 5,448 14,852     -
   Fouse Jacqualyn A Director   –       •      –    2024-01-20 4 OE $0.00 $0 D/D 23,900 139,975     -
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-01-20 4 OE $0.00 $0 D/D 5,750 33,619     -
   Burns James William Chief Legal Officer   •       –      –    2024-01-09 4 AS $22.99 $26,737 D/D (1,163) 26,336 31%     
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-01-09 4 AS $22.99 $41,129 D/D (1,789) 27,869 31%     
   Fouse Jacqualyn A Director   –       •      –    2024-01-09 4 AS $22.99 $192,909 D/D (8,391) 116,075 31%     
   Goff Brian Chief Executive Officer   •       •      –    2024-01-09 4 AS $22.99 $277,397 D/D (12,066) 40,053 31%     
   Burns James William Chief Legal Officer   •       –      –    2024-01-05 4 OE $0.00 $0 D/D 3,250 27,499     -
   Gheuens Sarah Chief Medical Officer   •       –      –    2024-01-05 4 OE $0.00 $0 D/D 5,000 29,658     -
   Fouse Jacqualyn A Director   –       •      –    2024-01-05 4 OE $0.00 $0 D/D 17,500 124,466     -
   Goff Brian Chief Executive Officer   •       •      –    2024-01-05 4 OE $0.00 $0 D/D 25,527 52,119     -
   Milanova Tsveta Chief Commercial Officer   •       –      –    2024-01-05 4 AS $22.32 $64,773 D/D (2,902) 9,404 36%     
  822 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 33
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us